Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Frankfurt - Delayed Quote EUR

STAAR Surgical Company (SR3.F)

Compare
16.20
-0.03
(-0.22%)
At close: April 2 at 8:02:06 AM GMT+2
Loading Chart for SR3.F
  • Previous Close 16.24
  • Open 16.20
  • Bid --
  • Ask --
  • Day's Range 16.20 - 16.20
  • 52 Week Range 12.78 - 47.99
  • Volume 7
  • Avg. Volume 124
  • Market Cap (intraday) 800.758M
  • Beta (5Y Monthly) 0.66
  • PE Ratio (TTM) --
  • EPS (TTM) -0.38
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

www.staar.com

1,157

Full Time Employees

December 27

Fiscal Year Ends

Recent News: SR3.F

View More

Performance Overview: SR3.F

Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SR3.F
29.78%
S&P 500 (^GSPC)
3.58%

1-Year Return

SR3.F
55.25%
S&P 500 (^GSPC)
8.94%

3-Year Return

SR3.F
77.60%
S&P 500 (^GSPC)
24.75%

5-Year Return

SR3.F
41.73%
S&P 500 (^GSPC)
124.42%

Compare To: SR3.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SR3.F

View More

Valuation Measures

Annual
As of 4/1/2025
  • Market Cap

    802.48M

  • Enterprise Value

    625.23M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.75

  • Price/Book (mrq)

    2.18

  • Enterprise Value/Revenue

    2.15

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -6.44%

  • Return on Assets (ttm)

    -1.55%

  • Return on Equity (ttm)

    -5.16%

  • Revenue (ttm)

    313.9M

  • Net Income Avi to Common (ttm)

    -20.21M

  • Diluted EPS (ttm)

    -0.38

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    230.49M

  • Total Debt/Equity (mrq)

    9.75%

  • Levered Free Cash Flow (ttm)

    15.79M

Research Analysis: SR3.F

View More

Company Insights: SR3.F

Research Reports: SR3.F

View More

People Also Watch